Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/151863
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHox, Valerie-
dc.contributor.authorLourijsen, Evelijn-
dc.contributor.authorJordens, Arnout-
dc.contributor.authorAasbjerg, Kristian-
dc.contributor.authorAgache, Ioana-
dc.contributor.authorAlobid, Isam-
dc.contributor.authorBachert, Claus-
dc.contributor.authorBoussery, Koen-
dc.contributor.authorCampo, Paloma-
dc.contributor.authorFokkens, Wytske-
dc.contributor.authorHellings, Peter-
dc.contributor.authorHopkins, Claire-
dc.contributor.authorKlimek, Ludger-
dc.contributor.authorMäkelä, Mika-
dc.contributor.authorMösges, Ralph-
dc.contributor.authorMullol i Miret, Joaquim-
dc.contributor.authorPujols Tarrés, Laura-
dc.contributor.authorRondon, Carmen-
dc.contributor.authorRudenko, Michael-
dc.contributor.authorToppila‑Salmi, Sanna-
dc.contributor.authorScadding, Glenis-
dc.contributor.authorScheire, Sophie-
dc.contributor.authorTomazic, Peter‑Valentin-
dc.contributor.authorVan Zele, Thibaut-
dc.contributor.authorWagemann, Martin-
dc.contributor.authorvan Boven, Job F. M.-
dc.contributor.authorGevaert, Philippe-
dc.date.accessioned2020-03-03T23:46:07Z-
dc.date.available2020-03-03T23:46:07Z-
dc.date.issued2020-01-03-
dc.identifier.issn2045-7022-
dc.identifier.urihttp://hdl.handle.net/2445/151863-
dc.description.abstractBecause of the inflammatory mechanisms of most chronic upper airway diseases such as rhinitis and chronic rhinosinusitis, systemic steroids have been used for their treatment for decades. However, it has been very well documented that - potentially severe - side-effects can occur with the accumulation of systemic steroid courses over the years. A consensus document summarizing the benefits of systemic steroids for each upper airway disease type, as well as highlighting the potential harms of this treatment is currently lacking. Therefore, a panel of international experts in the field of Rhinology reviewed the available literature with the aim of providing recommendations for the use of systemic steroids in treating upper airway disease.-
dc.format.extent27 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherBioMed Central-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1186/s13601-019-0303-6-
dc.relation.ispartofClinical and Translational Allergy, 2020, vol. 10-
dc.relation.urihttps://doi.org/10.1186/s13601-019-0303-6-
dc.rightscc by (c) Hox et al., 2020-
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/-
dc.sourceArticles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)-
dc.subject.classificationRinitis-
dc.subject.classificationGlucocorticoides-
dc.subject.otherRhinitis-
dc.subject.otherGlucocorticoids-
dc.titleBenefits and harm of systemic steroids for short- And long-term use in rhinitis and rhinosinusitis: an EAACI position paper-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.date.updated2020-02-27T11:03:32Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.idimarina6016514-
dc.identifier.pmid31908763-
Appears in Collections:Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)

Files in This Item:
File Description SizeFormat 
12474_6016514_13601_2019_article_303.pdf1.17 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons